RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$402.7M
Portfolio Weight
24.64%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$1.6B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
2M
Position Mix
No options reported
Reported Value
$402.7M
Portfolio Weight
24.64%
LQDA
Common StockLiquidia Corp
Reported Shares
8.1M
Position Mix
No options reported
Reported Value
$245.7M
Portfolio Weight
15.03%
ABVX
Depositary ReceiptAbivax S.A.
Reported Shares
1.6M
Position Mix
No options reported
Reported Value
$154.3M
Portfolio Weight
9.44%
PCVX
Common StockVaxcyte, Inc.
Reported Shares
2.2M
Position Mix
No options reported
Reported Value
$124.5M
Portfolio Weight
7.62%
EXEL
Common StockEXELIXIS, INC.
Reported Shares
1.6M
Position Mix
No options reported
Reported Value
$90.7M
Portfolio Weight
5.55%
TNGX
Common StockTango Therapeutics, Inc.
Reported Shares
2.5M
Position Mix
No options reported
Reported Value
$62.4M
Portfolio Weight
3.82%
ADMA
Common StockADMA BIOLOGICS, INC.
Reported Shares
5.9M
Position Mix
No options reported
Reported Value
$58.9M
Portfolio Weight
3.61%
IMCR
Depositary ReceiptImmunocore Holdings plc
Reported Shares
1.7M
Position Mix
No options reported
Reported Value
$50.6M
Portfolio Weight
3.10%
AVTX
Common StockAvalo Therapeutics, Inc.
Reported Shares
3.3M
Position Mix
No options reported
Reported Value
$50.1M
Portfolio Weight
3.07%
LBRX
Common StockLB PHARMACEUTICALS INC
Reported Shares
1.5M
Position Mix
No options reported
Reported Value
$49.6M
Portfolio Weight
3.04%
VRDN
Common StockViridian Therapeutics, Inc.\DE
Reported Shares
2.2M
Position Mix
No options reported
Reported Value
$45.2M
Portfolio Weight
2.76%
VOR
Common StockVor Biopharma Inc.
Reported Shares
1.9M
Position Mix
No options reported
Reported Value
$36.7M
Portfolio Weight
2.25%
IVA
Depositary ReceiptInventiva S.A.
Reported Shares
9.2M
Position Mix
No options reported
Reported Value
$33.9M
Portfolio Weight
2.07%
IRD
Common StockOpus Genetics, Inc.
Reported Shares
6M
Position Mix
No options reported
Reported Value
$28.9M
Portfolio Weight
1.77%
AURA
Common StockAura Biosciences, Inc.
Reported Shares
4.6M
Position Mix
No options reported
Reported Value
$28.8M
Portfolio Weight
1.76%
ANIK
Common StockAnika Therapeutics, Inc.
Reported Shares
1.4M
Position Mix
No options reported
Reported Value
$28.2M
Portfolio Weight
1.73%
SABS
Common StockSAB Biotherapeutics, Inc.
Reported Shares
8.7M
Position Mix
No options reported
Reported Value
$27.7M
Portfolio Weight
1.69%
SGMT
Common StockSagimet Biosciences Inc.
Reported Shares
2.8M
Position Mix
No options reported
Reported Value
$27.6M
Portfolio Weight
1.69%
FTH
Common StockFaeth Therapeutics, Inc.
Reported Shares
890.2K
Position Mix
No options reported
Reported Value
$26.5M
Portfolio Weight
1.62%
TYRA
Common StockTyra Biosciences, Inc.
Reported Shares
910.7K
Position Mix
No options reported
Reported Value
$19.9M
Portfolio Weight
1.22%